America’s New Space Race: How It Could Save Your Life, Double Your Money and Change the Way We Talk... All in the Next 12 Months

Dear Reader,

This issue turned out far more controversial than I planned.

Oh sure... I detail what I am convinced will be the hottest stock of 2020... and 2021... 2022... and beyond.

And, yes, I unveil new technology that could hand us the cure for cancer and a slew of other killer diseases.

But, as you’re about to see, it’s impossible to cover those topics these days without stepping a toe into the controversial.

It’s impossible, for instance, to write about technology without giving a nod to the problems it has created and will create.

And it’s impossible to talk about healthcare without tiptoeing into the shadows of political discussions.

Heck, the technology I debut in the pages that follow even begs us to debate the merits of government and its investments.

Indeed... readers will write me in angst.

But that’s okay. It comes with our mission.

My goal with every issue we publish is quite simple.

We must enrich readers’ lives by exploring our beloved Triad in new and different ways. It means we must expand Know-How... discuss why Liberty is essential... and share the value of rich, healthy Connections.

This issue does it all – even if the ideas it explores may be controversial.

Should Technology Be Feared? But before we get into it, there’s a story you must hear.

You’ve probably heard of the Luddites. And you probably know them as a band of folks who were vehemently anti-technology. That’s certainly the modern definition of the term. I’ve been called a Luddite many times thanks to my disdain of smartphones, streaming TV and all those other modern “must-haves.”

But the term – at least as it’s commonly used – is a bit of a misnomer.

When you consider the term’s original form, I’m anything but a Luddite. This issue proves it. And by the time you’re done reading it – all controversy aside – I think you’ll see things the way I do.

If anything, the original Luddites were an extreme labor organization. It wasn’t technology they hated. It was companies and their penny-pinching bosses using machines to get around rising wages and increased worker safety measures that they were against.

M A N W A R D letter

LIBERTY KNOW-HOW CONNECTIONS

Volume 4, February 2020

2know-how

They wouldn’t necessarily be against today’s iPhones, GMO technology and self-driving cars. They’d fight those trends only if they threatened their jobs and livelihood.

Most so-called Luddites (even that term is a bit of a joke, as their namesake hero never actually existed) were artisans and craftsmen. They worked in 18th-century textile mills weaving fabrics and preparing cotton for market.

For most folks today, having machinery do this work is a no-brainer. It’s efficient and far more productive. Paying folks to do tedious weaving would put any business right out of business.

But not in the late 1700s... Companies had no choice. The technology didn’t yet exist to pull humans off the job.

As you can guess... that all changed.

It’s no coincidence that just as textile workers were asking for higher wages, shorter working hours and better workplaces, technology was invented that could do things cheaper, longer and with no time off for a cut finger.

That’s simply the way the world works. If it didn’t... we could kiss all of our modern conveniences goodbye.

Henry Ford made a name for himself by putting his people alongside a moving assembly line. It worked. But you can bet the cars coming out of Detroit these days are rolling off a line that looks far different.

The natural instinct – especially if you’re the assembly-line worker – is to gripe about the jobs that are lost to automation. It hurts. It certainly does.

But cars today are cheaper... safer... faster... and some are nearly capable of driving themselves. That would not be possible if the Luddites marched into Ford’s factory and crushed the automated spot welders and robotic paint machines.

Technology in the name of progress is not bad. That’s where we so vehemently disagree with the original wearers of the Luddite moniker.

They were acting out of their own self-interest... caring very little about the effect on their society and its economy.

If technology does good – increases our Know-How, enhances our Liberty or enriches our Connections – we should all stand behind it.

But when it doesn’t – when it harms those ideas – we must shun it from our lives.

The ideas in this month’s issue, however, are not about shunning technology. In fact, they celebrate breakthroughs that most readers have likely never heard about.

But the issue does smack quite hard at the selfishness of old-school Luddites and their modern-day brethren. It doesn’t take much squinting to look around and spot modern-day folks who are selfishly protecting their jobs.

When Governments Step AsideThat’s the joy of the first article. It celebrates the private sector and capitalism. It shows us what happens when the folks in Washington stop protecting their jobs at the cost of the citizenry and let the free markets have their way.

Great things get done. And in this case... lives will be saved.

It’s incredible.

It shows the immense power of technology. We’re literally reaching for the stars and seeing great rewards for it.

But what’s crazy is this potential is years behind where it should be. After all, the government had its thumb on the industry for more than 50 years.

It did good things, no doubt. But now that it’s letting the free market in, the gains have been exponential.

I think you’ll be quite excited (and fascinated) by what’s happening.

My point with the first essay, though, isn’t just to introduce new technology that may save your life. I hope you read the piece and see the connections between it, the broader economy, politics and even our own lives.

This is where things get a bit controversial.

Lots of folks shun technology merely because it’s new. I’m guilty. I’ve often said if it’s not broke, don’t fix it.

But sometimes it takes a bit of a revolution – or a different way of thinking – for us just to see what’s broken.

That’s where the second essay comes in.

It outlines an immense profit opportunity. It’s one that many investors have overlooked.

know-how 3

You’ve surely heard about the investing craze surrounding 5G technology. It was one of the hottest sectors of 2019. But most folks are blind to what’s happening. The technology that’s promised is quite interesting... and useful. But there are some serious health concerns about dousing our bodies with that much radio-frequency radiation in such close proximity.

And even aside from the health concerns, frankly, there’s better technology on the way.

Luddite-minded investors will stick with what they already know... and totally miss out on what’s ahead.

That’s the big idea this month.

It’s even evident in my final essay... There’s been some recent news celebrating the fact that cancer rates are down. But the reason lives are being saved is up for debate.

There are a lot of good things happening. But it takes Know-How to spot them... and it takes a wise person to understand what’s good and what’s bad.

The words and pages ahead will help immensely.

Please enjoy them.

Be well,

Andy

How a Two-Headed Mutant Could Save Your Life – And Why the Government Is to BlameLook up.

Look way up there – past the ceiling, past the clouds – as far as you can see.

Something special is happening up there. It could change the way you live, the way we treat disease and the way we communicate (plus... keep reading to see why it will surely disappoint a slew of 5G investors).

To learn what I’ve uncovered, you need to hear about a bizarre two-headed monster... and its mutant offspring.

It’s probably something NASA doesn’t want you to hear, but it’s a true story.

The space agency recently did the same experiment I did when I was studying biology in school. It took planarian flatworms, cut them into pieces and studied the various ways the odd species regenerated new heads and new tails.

But NASA did something I could not have dreamed of back then. It sent some of the worms to the International Space Station for five weeks... and then it cut them in half.

What happened next stunned scientists.

The microbiology of the worms changed. Their sensitivity to light mutated. One group even grew two heads. And, the crazy part, when researchers snipped the two-headed monsters in half... both halves regrew another two heads.

“Normal flatworms in water never do this,” said Michael Levin, the study’s co-author.

The experts aren’t sure what’s going on or why the worms did what they did. They suspect it may have to do with the organism’s loss of its geomagnetic field or the effects of losing gravity.

Really, we don’t care why – at least not for our purposes today. We’re not in the worm business.

But we are in the business of ideas. And understanding what’s happening in the skies way above us is critical Know-How for anybody who wants to live healthier, feel better and get richer.

Space Race 2.0You see, thanks to studies like this one, we’re in the midst of a powerful space race... one with results that could soon far outpace anything we’ve ever seen before.

This space race 2.0 is exciting for several reasons. I’ll get to all of them in detail. But first, you need to know why it’s happening.

If you recall, America’s first big push into space came because we were scared. The Russians were knocking on our doorstep, and we needed technology to keep them at bay.

4know-how

Fear is a great motivator. It changed the shape of our nation. But greed is an even stronger motivator.

It’s what’s propelling so many American businesses into space. Companies like Boeing, Lockheed Martin and SpaceX are leading the way. But they’re not alone.

They may not be making the rockets or satellites, but companies like Apple, Amazon and Google are quietly going to space. And it’s not just the tech giants, either. A lot of folks are quite surprised when I tell them retail giant Target has done work in space and so have drug firms like Merck and AstraZeneca.

Some folks say these companies are working to build the “most exclusive business park for humankind.” It’s so remote... you have to hop on a spacecraft to get there.

But what’s great – and why these companies are so successful – is it’s not the government leading the missions. It’s the private sector.

Like I said, it’s no longer fear that’s propelling us into space. It’s greed.

That means it’s no longer tax dollars that are being burned in those rockets... It’s investor cash. And anytime the capitalist system is in charge, things get done much more efficiently and effectively.

This isn’t the first time the private sector has gone to space. In the 1980s, McDonnell Douglas (now Boeing) put one of its engineers on NASA’s shuttle. But when Challenger exploded in 1986, illusions of a grand partnership between the space agency and the private sector were dashed.

It took decades for the dream to get rebuilt. Shuttle launches were expensive and infrequent. Working on a limited budget with no way to earn a profit, NASA had no reason to make missions scalable.

But eventually the private sector got involved and is now – profitably – sending regular payloads to the International Space Station. And, proving the private sector always wins, in June of last year, NASA announced (on the floor of the Nasdaq exchange, mind you) that the space station would open for business.

That’s right. Private companies can now send their folks and their experiments to the lab floating 250 miles over our head. And we’ll see it in 2020.

It will surely result in some big breakthroughs. We’ve already seen a few.

Merck, for example, sent its cancer drug Keytruda to space for testing. Amgen used data collected from mice in space to develop its osteoporosis drug Prolia. And Schering-Plough reformulated one of its top drugs after doing research in space.

A recent poll showed that some 60% of drug company executives believe space research will significantly disrupt their business in the coming decades.

But here’s the thing. The space station is only so big. It can handle only so many folks and their experiments. Current guidelines (yes, I checked) limit private missions to the space station to just two flights per year, with just seven folks per trip.

Even if you can find a spot, a single 30-day trip could cost $59 million or more... just for one scientist.

Clearly there are some limits. The space station can’t provide a large-scale solution.

That’s where the private sector comes in. This is great.

Capitalism Saves the DayThere’s a tiny company working out of Israel and Switzerland that can get drug experiments in space for far less than what NASA charges. With a price tag of just $230,000, in fact, SpacePharma’s bill represents a mere fraction of the total cost of bringing a new drug to market.

And thanks to the company’s novel ideas, we could soon see a bevy of fresh space-based drugs down here on Earth.

The company rents what it calls “minilabs” and sends them into orbit for up to six months. It already has three of them in orbit, with plans for more in the near future.

SpacePharma’s model works because it cuts people out of the equation.

Instead of blasting a human – and all the high-tech life-support equipment they need – the company sends autonomous “kits” into orbit. The kits are about the size of a milk crate and contain everything that’s needed to conduct robust experiments in an environment without gravity.

5know-how

Everything is controlled remotely. Syringes and pumps can be manipulated by folks on Earth using a simple web interface.

It means dozens of tests can be conducted on one floating spacecraft, whereas the government-funded teams at NASA could pull off just one or two.

SpacePharma has helped with traditional tests involving things like bacteria, stem cells and muscle tissue. But it’s also a pioneer in something that’s possible only in space... something it calls an “organ on a chip.”

On Earth, a culture in a petri dish grows essentially in just two dimensions. But without gravity, it can grow in a third dimension in space. Up there, the tissue grows much more closely to how it would grow within the human body.

That’s important. It’s leading to a whole new type of science – one that, if all works well, could create the next generation of drug development and manufacturing circling the planet in low orbit. But here’s the best part of all of this. It changes the future of medicine.

Crowdfunding the Next Big BreakthroughWith capitalism taking to the stars, prices are falling and folks who never would have had access to the space station or similar venues are suddenly finding themselves just $230,000 away from breakthrough research.

As SpacePharma CEO Yossi Yamin explains, for example, imagine finding 250 people with the same rare disease. They no longer have to get the attention of Big Pharma and spend countless millions to do gravity-free research.

Now they can each pool a thousand bucks... create their test kit and blast it into space.

SpacePharma’s leaders are proud to say that several groups representing rare, virtually unstudied disorders have recently reached out to the company and are looking to get their experiments on board its test facilities.

And they aren’t alone.

Right now, any one of us can go online and book a “ride share” flight on a rocket into space. You can do it with just a couple of clicks of a mouse thanks to companies like Rocket Lab and Spaceflight. It’s almost as easy as ordering an Uber.

“We provide payload rideshare opportunities similar to how Expedia sells airline tickets,” said Curt Blake, the CEO of Spaceflight. “Making it easy and affordable is key to lowering the entry barriers to this market.”

That’s the power of capitalism. It’s what happens when the government gets out of the space race and lets the private sector in.

We’re about to see some really good things come from the skies way above us. For decades, space has been out of reach for all but a few. But things are changing quickly... and it’s all because greed has trumped fear.

Some say it could bring a cure to cancer. Others are hopeful rare diseases will be cured.

But the advances won’t all be related to our health. There’s enough room up there for everybody and a whole lot of breakthroughs. For more on that and how to make some serious money off this trend... keep reading.

THIS Is Doctor-Recommended for Fast Pain Relief (Hint: It’s NOT Pills)

Today we’re blowing the lid off the best-kept pain secret in the medical community. This ONE controversial solution could eliminate your pain, starting in 7 seconds or less. Dr. Sanjay Jain of Johns Hopkins Medicine says, “It’s a godsend.”

Greg B. got this solution for his ailing fiancée.

“She did not believe anything would work in 7 seconds,” Greg said. “When she finally tried it, she was amazed at how fast she felt relief!!! Now we are not allowed to travel anywhere without it. She thinks it is a miracle.”

To END your pain for good, visit www.ReliefinSevenSeconds10.com and use your promo code G323W200.

6liberty – stock recommendation

Andy Snyder has made his followers rich. After leaving one of the nation’s leading brokerages, Andy decided to take his wealth-exploding advice to the masses. Using his nearly two decades in the investing business to create award-winning model portfolios, he provides clear and easy-to-follow guidance on the best stocks to invest in each month in Manward Letter.

The Next Generation of Phone Tech Is Not 5G... It’s This Stock Everybody wants in on 5G.

It was one of the hottest investing trends of 2019.

But there’s something better than 5G. It’s coming soon. And it could make you rich... very rich.

I’ve followed this technology for several decades, starting when it was hardly even off the drawing board. And I’m convinced, now more than ever, that its day is coming soon.

You see, when I lived in Alaska, communications were tough. The nearest telephone pole was 40 miles away. A landline was out of the question. Cellphones didn’t work. And they still don’t work... even with all the promises of 5G.

All we had were radios. But they were based on World War II technology and could travel only so far.

But there was one thing that did work.

It was orange and black. And it was about the size of two decks of cards placed back to back.

I carried it with me everywhere I went – on floatplanes... on canoes... Who knows how many miles it traveled in my backpack. I used it often.

No matter where I went, or how remote I got, I could use this odd new-at-the-time device to send a message anywhere in the world. I could signal for my pilot to come pick me up. I could tell folks I was okay. Or if things got really bad, I could call in the troops and get a helicopter rescue in minutes.

Back then, the technology was quite expensive. Very few folks had it.

But that’s changed. And it’s about to change even faster.

Losing 5G SignalThat’s because of something that recently came from Apple (AAPL).

It hardly made the news, but somebody leaked something big just before Christmas. An insider at the company told a reporter that Apple has quietly hired a number of aerospace designers to work on satellite and antenna plans.

The company, in other words, is working on something that could entirely scrap the cellphone network we rely on today... and that includes 5G.

It ties directly back to that technology I used decades ago – a system that uses satellites, not antennas, to beam signals to users.

Back then, there were just a handful of satellites. It meant bandwidth was expensive and the cost to use one to send a message was quite prohibitive.

There’s no way it could handle even a fraction of the mobile traffic of today.

But as we’ve seen, the space race is heating up. Private companies are blasting satellites into space at a, well, skyrocketing rate.

In fact, at the same time Apple is working to get its signal into space, Elon Musk’s SpaceX has announced it’s planning to launch 42,000 satellites as part of its ambitious Starlink program.

Meanwhile, proving that this private sector space race is unlike anything we’ve ever seen from NASA or its international competition, Amazon just announced its own plans to launch 3,236 satellites as it aims to provide internet service across the globe – presumably to all of its potential shoppers.

Right now, for a sense of scale, there are just 2,000 operational satellites in orbit around Earth. If Musk, Bezos and company get what they want (they typically do), that number will rise exponentially over the coming years.

THIS MONTH’S STOCK PICK

7liberty – stock recommendation

That means what’s happening right now not only is monumental but also represents a huge groundswell that could be immensely profitable.

And – I think this is the best part – it threatens to disrupt a powerful network of cellphone carriers.

Apple to the RescueNobody likes paying their cellphone bill. It’s expensive and seems to rise every six months.

So imagine how many folks would like to stop writing a check to Verizon or AT&T each month. And imagine just how badly Apple would like you to send it some cash each month instead.

If it gets its way, it could happen... soon.

It’d be well worth the investment.

Apple not only would control much more of the current market but could quickly provide cheap and fast service (that rivals 5G) to all corners of the globe – not just hand-selected big cities.

Unlike cell signals that can be spotty and offer limited coverage, satellite signals can blanket the globe. That means parts of the world that are currently unserviced by cellphone providers would instantly get a signal... and the divine opportunity to cut a check to Apple each month.

Like I said, what’s happening is revolutionary.

Rocket StocksI’ve got some strong experience investing in the space sector.

If you’re a Manward Trader subscriber, you know what I mean. When my system picked up on Aerojet Rocketdyne (AJRD), I knew it was going to be a winner... no matter what the economy or the markets threw our way.

As a defense contractor and a leader in the modern space race, it’s a solid company that has treated investors well. Our position in Aerojet has surged by 95%... and it’s looking to climb even further in 2020.

But I’m not recommending you buy shares of Aerojet. As its price tag has nearly doubled, it’s ballooned into a nearly $4 billion company.

Instead, I want you to understand that it has soared thanks to the modern space race and its deep ties to government contracts. And I want that knowledge to inspire you to grab shares of a similar but much smaller company – a small cap firm with a price tag of less than a billion bucks – with even stronger prospects.

Plain and simple, Loral Space & Communications (LORL) is a satellite company. It owns a fleet of communications satellites and manages the operations of others.

But the company offers something that you can’t get anywhere else – a stake in an interesting private company called Telesat.

There are only two ways to put your hand under Telesat’s annual profit stream.

One way is through the Canadian government.

Its famed pension system owns roughly half of the company. Private investors can’t get in. Sorry.

The other way is through a stake in Loral, which owns 63% of the company.

You can get into that company... and you should.

Buy One... Get TwoLoral, overall, is a simple business. It owns majority stakes in Telesat and a company called Xtar. Both do similar things, but their markets are a bit different.

Telesat is most likely going to be a major driving force as everyday Americans start using a direct connection to satellites to communicate. It has a robust R&D lab, know-how and industry experience, and, this is important, it has Telesat LEO.

That’s its “low Earth orbit” network that is scheduled to begin operating in 2022. Once underway, the system will provide “fiber-like throughput anywhere on earth.”

That’s huge. It means Telesat and therefore Loral will be a leading player in the 5G sector. In fact, it will own much of the constellation of satellites that is needed to make it happen.

In other words, if you’re looking for a 5G stock that few folks are talking about... this is it.

But remember, 5G isn’t the kind of technology Apple and its Big Tech brethren are hoping for. 5G still relies on carriers like Verizon and AT&T to provide the final link.

But that’s okay... because Telesat is also a leader in the technology that will send ultra-fast, high-bandwidth satellite signals directly to your phone – completely bypassing carrier networks.

Take, for example, a recent breakthrough in wireless communications. A medical team on a remote Canadian island (similar to where I used to live) used one of Telesat’s satellites to communicate in real time with doctors in Calgary. And they not only were able to talk but could stream high-resolution ultrasound images to the team.

That’s huge. Again... it did it all without wires or relying on cellphone networks. It used satellites.

Surely that technology is on its way to you and me.

But remember, Loral generates a steady stream of government-backed revenue. That is what’s exciting about the other half of its business.

It’s Nuke-Proof, TooAgain, Loral owns a stake in Xtar, which focuses tightly on the defense sector. It provides the satellites our nation’s special forces rely on for their covert, high-risk operations. It also just announced it secured a deal to build new extreme-tech satellites that feature robust bandwidth capabilities, anti-jamming technology and world-class encryption... and they’re also nuke-proof.

That’s right. These satellites are designed to stand up to nuclear attacks. That shows how intelligently they are engineered and how valuable this technology is to our nation and therefore its enemies.

This is the stuff of the future.

I’m absolutely convinced we will look back in five years and think we were silly for ever filling our cities with ugly cellphone antennas and clogging our airwaves with lousy signals that may or may not be causing cancer.

Instead, we’ll be communicating across the world with satellites floating miles high over our heads.

8liberty – stock recommendation

How Satellites Lead to Safer CommunicationIf you’ve been with Manward for any amount of time, you know I’ve spilled a lot of ink on the health risks associated with cellphone radiation.

As more cities across America prepare for the widespread rollout of 5G networks, there’s plenty to be concerned about. The “heavy” signal 5G relies on can’t travel all that far. To overcome the issue, coverage providers are forced to virtually paint regions with antennas.

Stronger signals that require more transmitters means more waves of close-range – and harmful – radiation hitting us all the time.

While it’s true we don’t know the long-term effects of cellphone radiation (although we’ve seen scary results in studies with rats), we do know that the closer we are to the source of the signal, the more danger we’re in.

It’s why the Federal Communications Commission and major phone makers tell us to never hold our phones directly against our skin.

And this is a major reason I’m so excited about what Loral is doing with satellite communication. With the ability to transmit signals directly to the end user, the company could cut cellphone networks out of the equation.

That means eliminating close-range radiation.

The source of the signal is coming from space... a far cry from the forest of antennas surrounding us.

Loral and its subsidiaries will pave the way for safer communication... and disrupt an entire industry while doing so. Expect more companies to jump on board with this technology. But we’ll be ahead of the curve by putting Loral into our portfolio.

We may be on the fifth generation of cellphone signals... but when it comes to wireless communications, satellites represent the powerful (and very profitable!) second generation.

Invest now, and get in ahead of everybody else.

The No. 1 Way to Cure CancerThere’s reason to celebrate.

Things may be lousy in the realm of politics. And the economy may be rigged and doomed for eventual trouble.

But as we’ve shown over the last few pages, the private sector is alive and healthy.

And now we learn that it’s saving lives.

Good news was released recently.

The death rate for cancer patients is falling.

In fact, during the most recent period that was studied (from 2016 to 2017), the rate fell by 2.2%... the fastest decline on record.

That doesn’t sound like much, but it’s huge.

Strung together, the number of folks who die from cancer has dropped by 29% since the peak in the 1990s.

That’s nearly 3 million souls spared.

The reason lives are being spared, of course, is up for some debate.

But when we dig into it – not with an agenda, but to seek the truth – we see that what is happening is yet another big win for our beloved Triad.

Truth Be ToldIt is important to note that I am not against Big Pharma.

You can bet if my doc told me today that I have cancer, I too would be looking at the latest drugs from the oh-so-profitable drug industry.

They save lives. There is no doubt.

But we can’t be ignorant, either. Big Pharma is a bully.

It pushes aside the unprofitable for the profitable... no matter whether the former works better than the latter.

It pushes high tech over low tech because one makes a lot more money than the other.

Big Pharma will never slap its label on a bottle of haymaker punch... despite its many proven health benefits. It’d rather sell us a pill that we take for life or push a six-figure treatment than hand us a nutrient-packed supplement that aims to eliminate trips to the doc altogether.

The modern drug industry and therefore much of the industrial health complex are not in the business of prevention.

They make their money after we get sick.

That’s what’s crazy about these latest statistics.

They represent a huge win for so much of what we’ve published over the last 18 months.

Get this... Cancer death rates have dramatically fallen over the last three decades not because we’re significantly better at treating the disease.

No. It’s because we’re way better at preventing it.

Proving the point are the dwindling numbers of lung cancer and melanoma deaths leading the charge lower.

Death rates for lung cancer, for example, have plunged – down from their peaks by 51% for men and 26% for women.

Why?

It’s quite simple. It’s Know-How – perhaps the most potent of the three pieces of our Triad.

9know-how

Action to Take: Buy shares of Loral Space & Communications (Nasdaq: LORL) at the market price. We will add this position to our Everyman Portfolio and use our standard 25% trailing stop.

10

Stop Causing CancerAfter nearly a generation of ignorance and debate from the medical community (remember, some docs actually used to prescribe cigarettes), folks wised up and realized smoking was not only bad for us but also a leading killer.

Once Americans realized their doc had been hoodwinked by Big Tobacco (a fierce panel of industry-backed doctors actually appeared before Congress to fight the surgeon general report that definitively linked cigarettes with larynx cancer), they quit smoking, cancer rates plunged and lives were spared.

In other words, it’s not Big Pharma saving all these folks... It’s Big Truth.

In fact, if we remove lung cancer from the math, the decline in cancer rates over the most recent period is cut nearly in half – down to just 1.4%.

That’s vital to understand.

It shows why I’m such a fierce proponent of uncovering the truth. It’s why I went to the FDA to speak about CBD. It’s why I’ve researched so much about cellphone radiation. And its why I’ve spent the last two years building up a team of doctors and researchers to help me publish all of these ideas.

Medicine will save your life. There have been huge breakthroughs in treating cancer.

But wouldn’t you rather not get it in the first place?

If so... Know-How is the very best medicine. My intent is to give you a heaping dose of it.

But, again, I am not entirely opposed to the science Big Pharma is touting. It is saving lives.

It ties directly to what I detailed in our annual prediction issue.

Let’s Get PersonalLast month, I wrote to you about my excitement for the realm of personalized medicine.

For too long, we’ve been going to the doc, showing a set of symptoms, and getting the same drug or treatment as everybody else with those same symptoms.

But we all know our bodies are different. We’ve got unique genes and unique chemical makeups that make medicines react differently in my body than they would in yours.

Until very recently, doctors could only acknowledge the fact and not do a whole lot about it. But over the last few years, the realm of personalized medicine has made huge leaps forward.

And it’s evident in this latest batch of data...

This is where Big Pharma – or at least the small, tech-forward side of the industry – deserves a pat on the back.

Take melanoma, for instance.

Next to lung cancer, this deadly form of skin cancer saw the largest drop in its death rate during the latest sample period.

In other words, a melanoma diagnosis is not as deadly now as it was five years ago.

Why? It’s all about personalized medicine.

You see, doctors have recently begun testing cancer at the genetic level. They look for the presence of specific markers and mutations. Based on what they see, they can now get very specific with their treatments.

When it comes to melanoma, Genentech has made large, life-saving strides with its drug Zelboraf. Not to get too scientific, but it gets prescribed to patients who have a specific BRAF V600E gene mutation, present in about 50% of melanoma patients.

Thanks to this innovation and others related to immunotherapy, which uses the body’s powerful and little-understood immune system to fight cancer, one-year survival rates for melanoma patients have surged by about 50% in recent years.

That’s huge. But I still can’t help but look at the numbers and spot the glaring and obvious takeaway.

The Triad Wins AgainThe very best cancer cure is Know-How.

As the world realized that smoking cigarettes is incredibly dangerous and that the leading cause of skin cancer can be prevented by covering up and lathering up... rates of the deadly disease fell.

know-how

1 1portfolios

The Own What You Know Portfolio

Company/Symbol Rec. Date Rec. Price Curr. Price Rating Trailing Stop Total Gains

AGCO (NYSE: AGCO) Aug-19 $70.29 $74.51 Buy $60.51 6.46%

Air Products and Chemicals (NYSE: APD) Sep-19 $225.38 $236.86 Buy $180.09 6.12%

Alamo Group (NYSE: ALG) Oct-18 $90.33 $125.01 Buy $97.31 39.05%

Copart (Nasdaq: CPRT) Nov-18 $50.30 $96.26 Buy $71.48 91.37%

Flagstar Bancorp Inc. (NYSE: FBC) May-19 $35.25 $37.82 Buy $29.31 7.63%

Graco Inc. (NYSE: GGG) Nov-19 $46.98 $53.21 Buy $39.78 13.26%

Visa (NYSE: V) Sep-18 $147.80 $195.33 Buy $145.33 33.04%

Zoetis Inc. (NYSE: ZTS) Mar-19 $95.72 $136.51 Buy $101.68 43.13%

Last Update: 1/13/20. Gains include dividends.

The Everyman Portfolio

Company/Symbol Rec. Date Rec. Price Curr. Price Rating Trailing Stop Total Gains

Assurant Inc. (NYSE: AIZ) Apr-17 $95.11 $132.47 Buy $100.98 45.94%

CACI International (NYSE: CACI) Feb-19 $172.51 $265.49 Buy $197.30 53.90%

Constellation Brands (NYSE: STZ) Dec-18 $193.21 $188.44 Buy $157.60 -0.92%

Golub Capital BDC (Nasdaq: GBDC) May-18 $17.96 $18.38 Buy $12.73 16.26%

Herc Holdings (NYSE: HRI) Jun-19 $37.91 $45.35 Buy $37.79 19.63%

Jazz Pharmacueticals (Nasdaq: JAZZ) Jan-20 $144.37 $145.85 Buy $110.01 1.03%

Loral Space and Communications (Nasdaq: LORL)

Feb-20 New New Buy 25% TS New

ProShares Short FTSE China 50 ETF (NYSE: YXI)

Jan-19 $21.42 $17.22 Buy $16.07 -18.76%

ResMed Inc. (NYSE: RMD) Oct-17 $76.53 $158.27 Buy $118.19 111.13%

Smith & Nephew (NYSE: SNN) Dec-19 $43.80 $48.51 Buy $36.56 10.75%

Waste Management Inc. (NYSE: WM) Apr-17 $72.84 $117.66 Buy $101.65 68.65%

The correlations are clear and obvious. It’s not breakthroughs in treatments that have saved so many folks. They’ve helped, for sure. But the No. 1 cancer buster is Know-How.

That’s why I do what I do. It’s why I study our food... our water... our technology. And it’s why I don’t take anybody’s word for it. The world has been duped and deceived too many times before.

It’s also why Manward is printing more health-related material than ever before. Not only will we make you rich these days... we may just save your life.

Stay tuned for more in our new mid-monthly health-focused issues. We’ve got lots to cover and lots of Know-How to explore.

Clearly, it makes a difference. n

About the cover image:

Do roses smell as sweet... in outer space? In 1998, the company International Flavors & Fragrances partnered with NASA to send a miniature rose aboard space shuttle Discovery. Their mission: to find out how the scent of a rose changed in space. Astronauts took several samples of its essential oils (that give a rose its scent) during the journey. Researchers were stunned to discover the effects of space caused the rose to produce an entirely new scent... one that was then bottled and made available commercially.

Cancer Mortality Rates Are FallingCancer death rate per 100,000 people in the U.S.

1970 1980 1990 2000 2010 2017

Source: Statista

249.3

163

271.1

165.8

279.8

174.6

248.5

166.7208.8

145.7181.4

131.2

Male Female

Telesat LEO Network

Source: Company Reports

Telesat has developed a highly innovative global network composed of about 300 state-of-the-art low Earth orbit (LEO) satellites, seamlessly integrated with on-ground data networks.

Telesat LEO Positioned for Speed

Source: Company Reports

The farther a satellite is from Earth, the higher the latency (round-trip time).

Relative Distance of Satellites From Earth1x = 1,000 kilometers

Round-Trip TimeMilliseconds

LEO MEO GEO

GEO: 35x600-800

125-25030-50

MEO: 35x

LEO: 1x

12

© 2020 Manward Press | All Rights Reserved

Manward Press is a financial and wellness publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by Manward Press should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties.

The information found in this newsletter may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Manward Press, 14 West Mount Vernon Place, Baltimore, MD 21201. Manward Letter is published monthly for $149 per year by Manward Press, 14 West Mount Vernon Place, Baltimore, MD 21201, www.manwardpress.com.

Further Reading

“Worm Grows 2 Heads in Space, Surprising Scientists,” Live Science: https://www.livescience.com/59461-worm-grows-two-heads-in-space.html.

“So, You Want to Be a Space Tourist?” Observer: https://observer.com/2019/06/international-space-station-commercial-business-tourism/.

“NASA Is Opening the International Space Station to Private Astronauts,” Quartz: https://qz.com/1638068/nasa-opens-international-space-station-to-private-astronauts/.

“Big Tobacco Led Throat Doctors to Blow Smoke,” Stanford Medicine: https://med.stanford.edu/news/all-news/2012/01/big-tobacco-led-throat-doctors-to-blow-smoke.html.

Appendix